Ignite Creation Date:
2024-05-06 @ 2:36 AM
Last Modification Date:
2024-10-26 @ 11:21 AM
Study NCT ID:
NCT02082977
Status:
TERMINATED
Last Update Posted:
2020-02-25
First Post:
2014-01-16
Brief Title:
A Study to Investigate the Safety Pharmacokinetics Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With RelapsedRefractory Diffuse Large B Cell Lymphoma Transformed Follicular Lymphoma Other Non-Hodgkins Lymphomas Solid Tumors and Multiple Myeloma
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-04-24
Start Date Type:
ACTUAL
Primary Completion Date:
2017-06-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06-20
Completion Date Type:
ACTUAL
First Submit Date:
2014-01-16
First Submit QC Date:
March 6 2014
Study First Post Date:
2014-03-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2019-06-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-17
Last Update Post Date:
2020-02-25
Last Update Post Date Type:
ACTUAL